Periprocedural Oral Hydration Patterns and Early Renal Function after Coronary Angiography and Intervention: A Prospective Real-World Cohort Study.

IF 3.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Cardiorenal Medicine Pub Date : 2026-01-01 Epub Date: 2025-12-31 DOI:10.1159/000550260
Dan Zhu, Lingling Gao, Nanhui Zhuang, Yuan Ma, Lijing Fan, Haiyan Ma, Yimei Zheng
{"title":"Periprocedural Oral Hydration Patterns and Early Renal Function after Coronary Angiography and Intervention: A Prospective Real-World Cohort Study.","authors":"Dan Zhu, Lingling Gao, Nanhui Zhuang, Yuan Ma, Lijing Fan, Haiyan Ma, Yimei Zheng","doi":"10.1159/000550260","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Guidelines recommend oral hydration (OH) to prevent contrast-associated acute kidney injury (CA-AKI) after coronary angiography or intervention, but quantitative protocols are lacking, and practice varies. Shorter hospital stays limit opportunities for post-procedure creatinine monitoring, and real-world OH patterns and their early renal effects remain poorly described. This study aimed to characterize periprocedural weight-adjusted OH trajectories and to assess whether trajectory membership was associated with a change in serum creatinine within 24 h.</p><p><strong>Methods: </strong>This single-center prospective cohort study enrolled 192 inpatients undergoing coronary angiography or intervention between November 2024 and May 2025. We recorded weight-adjusted oral intake in four windows: pre-12 h, post-0-6 h, 6-12 h, and 12-24 h. We computed partial-overlap dynamic time warping distances and clustered trajectories using partitioning around medoids. Group comparisons used nonparametric tests. The primary outcome was percent change in serum creatinine, and dose-response was assessed with generalized additive models (GAMs) adjusted for baseline creatinine, estimated glomerular filtration rate, comorbidities, procedural indication, contrast volume, and intravenous hydration.</p><p><strong>Results: </strong>After excluding 18 patients for missing periprocedural oral intake or post-procedure creatinine, 174 patients were analyzed (median age 65.0 years, IQR 57.2 to 72.0; 71.8% male). Median weight-adjusted cumulative oral intake was 10.9, 18.6, 23.9, and 33.3 mL/kg for the pre-12 h, post-0-6 h, 0-12 h, and 0-24 h windows. Time-series clustering produced two stable groups (low-OH n = 85, high-OH n = 89; average silhouette = 0.393; bootstrap adjusted Rand index = 0.845). The largest between-group difference occurred in the 0-6 h window (median 4.12 vs. 2.00 mL/kg/h, p < 0.001). No patient met CA-AKI criteria. In adjusted GAMs, the 0-6 h OH rate was not a significant smooth term (edf = 3.79, p = 0.795), and cluster membership was not associated with creatinine change. However, the high-OH cluster had substantially greater 6-h urine output and a larger positive fluid balance (p < 0.001), while serum potassium was similar between clusters.</p><p><strong>Conclusion: </strong>Periprocedural OH was generally ample and formed two reproducible patterns. Concentrating oral intake in the first 6 h increased early urine output and positive fluid balance but did not show a significant dose-response association with early serum creatinine change. This null result should be interpreted cautiously because the cohort was generally low-risk, follow-up was short, and the study had limited power. Future studies should validate whether early concentrated OH protects renal function using earlier sensitive biomarkers and by targeting high-risk patients.</p>","PeriodicalId":9584,"journal":{"name":"Cardiorenal Medicine","volume":" ","pages":"25-36"},"PeriodicalIF":3.2000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12872192/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiorenal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000550260","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/31 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Guidelines recommend oral hydration (OH) to prevent contrast-associated acute kidney injury (CA-AKI) after coronary angiography or intervention, but quantitative protocols are lacking, and practice varies. Shorter hospital stays limit opportunities for post-procedure creatinine monitoring, and real-world OH patterns and their early renal effects remain poorly described. This study aimed to characterize periprocedural weight-adjusted OH trajectories and to assess whether trajectory membership was associated with a change in serum creatinine within 24 h.

Methods: This single-center prospective cohort study enrolled 192 inpatients undergoing coronary angiography or intervention between November 2024 and May 2025. We recorded weight-adjusted oral intake in four windows: pre-12 h, post-0-6 h, 6-12 h, and 12-24 h. We computed partial-overlap dynamic time warping distances and clustered trajectories using partitioning around medoids. Group comparisons used nonparametric tests. The primary outcome was percent change in serum creatinine, and dose-response was assessed with generalized additive models (GAMs) adjusted for baseline creatinine, estimated glomerular filtration rate, comorbidities, procedural indication, contrast volume, and intravenous hydration.

Results: After excluding 18 patients for missing periprocedural oral intake or post-procedure creatinine, 174 patients were analyzed (median age 65.0 years, IQR 57.2 to 72.0; 71.8% male). Median weight-adjusted cumulative oral intake was 10.9, 18.6, 23.9, and 33.3 mL/kg for the pre-12 h, post-0-6 h, 0-12 h, and 0-24 h windows. Time-series clustering produced two stable groups (low-OH n = 85, high-OH n = 89; average silhouette = 0.393; bootstrap adjusted Rand index = 0.845). The largest between-group difference occurred in the 0-6 h window (median 4.12 vs. 2.00 mL/kg/h, p < 0.001). No patient met CA-AKI criteria. In adjusted GAMs, the 0-6 h OH rate was not a significant smooth term (edf = 3.79, p = 0.795), and cluster membership was not associated with creatinine change. However, the high-OH cluster had substantially greater 6-h urine output and a larger positive fluid balance (p < 0.001), while serum potassium was similar between clusters.

Conclusion: Periprocedural OH was generally ample and formed two reproducible patterns. Concentrating oral intake in the first 6 h increased early urine output and positive fluid balance but did not show a significant dose-response association with early serum creatinine change. This null result should be interpreted cautiously because the cohort was generally low-risk, follow-up was short, and the study had limited power. Future studies should validate whether early concentrated OH protects renal function using earlier sensitive biomarkers and by targeting high-risk patients.

Abstract Image

Abstract Image

冠状动脉造影和干预后围手术期口服水合模式和早期肾功能:一项前瞻性现实世界队列研究。
导言:指南建议在冠状动脉造影或介入治疗后口服水合剂以预防造影剂相关的急性肾损伤(CA-AKI),但缺乏定量方案,实践也各不相同。较短的住院时间限制了术后肌酐监测的机会,而现实世界的口服水合模式及其早期肾脏影响仍然缺乏描述。本研究旨在描述围手术期体重调整口服水合作用(OH)轨迹,并评估轨迹成员是否与24小时内血清肌酐的变化有关。方法:这项单中心前瞻性队列研究纳入了2024年9月至2025年6月期间接受冠状动脉造影或介入治疗的192例住院患者。我们在四个窗口记录体重调整后的口服摄入量:12小时前、0-6小时后、6-12小时和12-24小时。我们计算了部分重叠的动态时间翘曲距离,并使用围绕介质的划分来聚类轨迹。组间比较采用非参数检验。主要结局是血清肌酐变化百分比,剂量反应评估采用广义加性模型(GAMs)调整基线肌酐、肾小球滤过率、合并症、手术指征、造影剂体积和静脉水化。结果:在排除了18例术中口服摄入或术后肌酐缺失的患者后,分析了174例患者(平均年龄63.3±11.4岁,71.8%为男性)。在12小时前、0-6小时后、0-12小时和0-24小时窗口,体重调整后的累积口服摄入量中位数分别为10.9、18.6、23.9和33.3 mL/kg。时间序列聚类产生两个稳定组(Low-OH n = 85, High-OH n = 89;平均剪影= 0.393;bootstrap ARI = 0.845)。最大的组间差异发生在0-6小时窗口(中位数4.12 vs 2.00 mL/kg/h, p < 0.001)。无患者符合CA-AKI标准。在调整后的GAMs中,0-6 h口服水化率不是一个显著的平滑项(edf = 0.16, p = 0.21),聚类隶属度与肌酐变化无关。然而,高oh组的6小时尿量和阳性体液平衡显著增加(p < 0.001),而血清钾在组间相似。结论:围术期口服水分基本充足,并形成两种可重复性模式。前6小时集中口服摄入增加了早期尿量和阳性体液平衡,但与早期血清肌酐变化没有明显的剂量反应关联。该无效结果应谨慎解释,因为该队列通常是低风险的,随访时间短,研究的效力有限。未来的研究应该使用早期敏感的生物标志物和针对高危患者来验证早期浓缩口服水化是否能保护肾功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiorenal Medicine
Cardiorenal Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-UROLOGY & NEPHROLOGY
CiteScore
5.40
自引率
2.60%
发文量
25
审稿时长
>12 weeks
期刊介绍: The journal ''Cardiorenal Medicine'' explores the mechanisms by which obesity and other metabolic abnormalities promote the pathogenesis and progression of heart and kidney disease (cardiorenal metabolic syndrome). It provides an interdisciplinary platform for the advancement of research and clinical practice, focussing on translational issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书